ETLI.DE vs. WELG.DE
ETLI.DE (L&G Pharma Breakthrough UCITS ETF) and WELG.DE (Amundi S&P Global Health Care ESG UCITS ETF EUR Dist) are both Health & Biotech Equities funds - ETLI.DE tracks the Solactive Pharma Breakthrough Value while WELG.DE tracks the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care. Both are passively managed. Over the past 3 years, ETLI.DE returned 2.83%/yr vs 2.22%/yr for WELG.DE. A 0.55 correlation means they provide meaningful diversification when combined. ETLI.DE charges 0.49%/yr vs 0.18%/yr for WELG.DE.
Performance
ETLI.DE vs. WELG.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETLI.DE achieves a -0.74% return, which is significantly higher than WELG.DE's -3.60% return.
ETLI.DE
- 1D
- 2.62%
- 1M
- -3.54%
- YTD
- -0.74%
- 6M
- -2.98%
- 1Y
- 21.87%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
WELG.DE
- 1D
- 2.97%
- 1M
- 4.19%
- YTD
- -3.60%
- 6M
- -3.05%
- 1Y
- 6.88%
- 3Y*
- 2.22%
- 5Y*
- —
- 10Y*
- —
ETLI.DE vs. WELG.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | 3.03% |
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | -3.60% | 1.26% | 7.51% | 1.94% | 4.13% |
Correlation
The correlation between ETLI.DE and WELG.DE is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Oct 12, 2022 | 0.55 |
The correlation between ETLI.DE and WELG.DE has been stable across timeframes, ranging from 0.54 to 0.58 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETLI.DE vs. WELG.DE — Risk / Return Rank
ETLI.DE
WELG.DE
ETLI.DE vs. WELG.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETLI.DE | WELG.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.69 | ||
| Sortino ratioReturn per unit of downside risk | +0.94 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.09 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.40 | 0.55 | +1.85 |
| Martin ratioReturn relative to average drawdown | 6.79 | 1.29 | +5.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ETLI.DE | WELG.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 0.47 | +0.69 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.22 | 0.00 |
Drawdowns
ETLI.DE vs. WELG.DE - Drawdown Comparison
The maximum ETLI.DE drawdown since its inception was -30.83%, which is greater than WELG.DE's maximum drawdown of -23.11%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and WELG.DE.
Loading charts...
Drawdown Indicators
| ETLI.DE | WELG.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.83% | -23.11% | -7.72% |
Max Drawdown (1Y)Largest decline over 1 year | -9.06% | -12.38% | +3.32% |
Max Drawdown (3Y)Largest decline over 3 years | -24.43% | -23.11% | -1.32% |
Max Drawdown (5Y)Largest decline over 5 years | -30.83% | — | — |
Current DrawdownCurrent decline from peak | -4.86% | -12.09% | +7.23% |
Average DrawdownAverage peak-to-trough decline | -10.22% | -7.24% | -2.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.21% | 5.34% | -2.13% |
Volatility
ETLI.DE vs. WELG.DE - Volatility Comparison
L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a higher volatility of 6.89% compared to Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE) at 5.31%. This indicates that ETLI.DE's price experiences larger fluctuations and is considered to be riskier than WELG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETLI.DE | WELG.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 5.31% | +1.58% |
Volatility (6M)Calculated over the trailing 6-month period | 14.09% | 10.25% | +3.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.72% | 14.54% | +4.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.22% | 13.49% | +3.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.91% | 13.49% | +5.42% |
ETLI.DE vs. WELG.DE - Expense Ratio Comparison
ETLI.DE has a 0.49% expense ratio, which is higher than WELG.DE's 0.18% expense ratio.
Dividends
ETLI.DE vs. WELG.DE - Dividend Comparison
ETLI.DE has not paid dividends to shareholders, while WELG.DE's dividend yield for the trailing twelve months is around 1.55%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% |
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | 1.55% | 1.36% | 0.92% | 0.17% |
Frequently Asked Questions
ETLI.DE and WELG.DE have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WELG.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WELG.DE is cheaper with a 0.18% expense ratio, compared with 0.49% for ETLI.DE.
ETLI.DE tracks Solactive Pharma Breakthrough Value, while WELG.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care. They also come from different issuers: Legal & General and Amundi. Their fees differ too: 0.49% for ETLI.DE and 0.18% for WELG.DE.
Find the right allocation for ETLI.DE and WELG.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer